Diabetic-retinopathy concerns with GLP-1 agonists allayed

More risk with insulin therapy study suggests

Contrary to previous reports, glucagon-like receptor-1(GLP-1) agonists do not appear to increase patients' risk of diabetic retinopathy, according to research based on UK data.